First sales data fires up shares in Mesoblast Group
MELBOURNE: Biotech Mesoblast has reported strong initial sales of its cell therapy, Ryoncil, ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
